Vikas Lifecare secured new orders totaling approx. ₹115 Crore for polymer compounds, enhancing market position.

It's expanding D-Mannose capacity by 300 MTPA.

A board meeting is scheduled to consider the financial results for the quarter and nine-month periods, new business activities, and potential issuance of convertible securities and bonus shares/stock split.